Shifting the Paradigm to Pragmatic Evidence Generation
Integrated evidence generation (IEG) is a framework for generating evidence to support regulatory decision-making in healthcare, automate real-world data collection and grow evergreening data networks that fuel a variety of needs.
› READ THE BLOGPOSTERS
Real-World Characterization and Management of Alopecia Areata Patients in the U.S.
MAY 16, 2023
View our poster on Real-World Characterization and Management of Alopecia Areata Patients in the U.S. Click to view!
Machine Learning Models to Estimate Disease Activity Measures in RealWorld Data Sources: Lessons Learned from Four Autoimmune Diseases
MAY 16, 2023
View our poster on Machine Learning Models to Estimate Disease Activity Measures in RealWorld Data Sources: Lessons Learned from Four Autoimmune Diseases. Click to view!
EVENTS
American Psychiatric Association Annual Meeting
MAY 16, 2023
When: May 20-24 Where: Moscone Center, San Fransisco, CA Booth Location: 1135 Events On Site: Panel Presentation Treatment Resistant Depression from Multiple Perspectives: Does It Exist? In partnership with Compass Pathways Saturday, May 20 1:30 pm – 3:00 pm Room 303 Moscone South Poster Presentation Use of Medical Language Processing in Real-World Data to Understand[…]
ISPOR Annual Meeting
MAY 16, 2023
When: May 6-10 Where: Boston Convention and Exhibit Center, Boston, MA Booth Location: 716 Events On Site: Poster Presentations Real-World Characterization and Management of Alopecia Areata Patients in the U.S. Monday, May 8, 2023 Poster Session 2 Poster Code: RWD62 Poster session time: 3:15 PM – 6:45 PM Presentation time: 5:45 PM – 6:45 PM[…]
EBOOKS
Real-World Analysis & Insights from the OM1 Neuroscience Specialty Network
NOV 27, 2023
OM1 is reimagining real-world evidence with the development of large, electronically connected networks of clinicians in key specialty areas. This ebook explores powerful insights, analyses, and use cases that leverage AI and data science from OM1’s Neuroscience Specialty Network. View ebook >>
Analyses & Insights from the OM1 Lupus Data Network Ebook
MAY 16, 2023
At OM1, we use RWD to create digital data networks to answer research questions and improve patient outcomes. In this E-Book you will find a sampling of: Market trends Data on Lupus Subtypes Artificial Intelligence Applications Case studies And more! Download>> *Due to proprietary information contained in our materials, we do not currently distribute them[…]
VIDEOS
Multiple Sclerosis eEDSS – Data Science Point of View
APR 13, 2023
Costas Boussios, Chief Data Scientist, OM1 details estimated EDSS score for Multiple Sclerosis were developed.
NEWS & ARTICLES
How is Artificial Intelligence Growing Up?
MAR 14, 2024
Dermatology Times March 10, 2024 Kaitlyn Bader Read the full article >> At the 2024 American Academy of Dermatology Annual Meeting in San Diego, California, Joseph Zabinski, PhD, MEM, the managing director of artificial intelligence (AI) and personalized medicine at OM1, a real-world data, AI, and technology company with a focus on chronic diseases, sat down with Dermatology[…]
Integrating Ambient Clinical Voice Technology – The Impacts, Challenges, and Benefits
MAR 11, 2024
Healthcare IT Today March 8, 2024 Read the full article >> Joseph Zabinski, Ph.D. VP, Head of Commercial Strategy & AI at OM1 Dr. Carl Marci, Chief Clinical Officer, Chief Psychiatrist and Managing Director of Mental Health and Neuroscience at OM1 The industry is seeing an uptick of ambient voice technologies used to help increase the efficiency,[…]
WHITE PAPERS
From Big Data to Measurable Outcomes: OBC
JUL 6, 2017
A heightened focus on value is driving efforts across health care to improve outcomes and reduce costs. For pharmaceutical companies, this focus translates into a shift away from traditional payment models to more outcomes-based, risk sharing agreements. In many ways, these agreements present the opportunity to better align interests across health care’s stakeholders. However, they[…]
Improving Performance under Bundled Care
NOV 5, 2016
The field of medicine is changing rapidly due to two major disruptions – the application of artificial intelligence, such as machine and deep learning and the shift from fee-for-service to value-based payment models. These innovations, which are occurring simultaneously, are fundamentally altering how data are used and how care is provided. To survive in this[…]
WEBINARS
Integrated Evidence Generation: Exploring Registries in the Era of Automation
FEB 28, 2024
Thu, Mar 28, 2024 2:00 PM – 3:00 PM EDT Presenters: Sonja Wustrack, MPH, Managing Director, Integrated Evidence Generation and Michelle Leavy, MPH Director, Real-World Evidence Strategy Register >> Integrated evidence generation is gaining traction in the biopharmaceutical industry as an approach to aligning evidence needs across functions within a company. Real-world data and real-world[…]
AI and Digital Phenotyping for Clinical Development
JAN 16, 2024
Wed, Jan 31, 2024 2:00 PM – 3:00 PM EST Register here >> With the new year comes even more hype with how AI will transform the healthcare and pharmaceutical landscape – including McKinsey estimating that AI technology could generate up to $110 billion a year in economic value for the pharma and medical-product industries.[…]